143 related articles for article (PubMed ID: 31372147)
1. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy.
Onalan E
Pak J Med Sci; 2019; 35(4):1081-1086. PubMed ID: 31372147
[TBL] [Abstract][Full Text] [Related]
2. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.
Karatas A; Turkmen E; Erdem E; Dugeroglu H; Kaya Y
Biomark Med; 2018 Sep; 12(9):953-959. PubMed ID: 30043636
[TBL] [Abstract][Full Text] [Related]
3. Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes.
Tekin BG; Pektaş E
Ir J Med Sci; 2024 Jun; 193(3):1283-1287. PubMed ID: 38366276
[TBL] [Abstract][Full Text] [Related]
4. The blood monocyte to high density lipoprotein cholesterol ratio (MHR) is a possible marker of carotid artery plaque.
Xi J; Men S; Nan J; Yang Q; Dong J
Lipids Health Dis; 2022 Dec; 21(1):130. PubMed ID: 36463176
[TBL] [Abstract][Full Text] [Related]
5. Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy.
Tang X; Tan Y; Yang Y; Li M; He X; Lu Y; Shi G; Zhu Y; Nie Y; Li H; Mu P; Chen Y
Front Cardiovasc Med; 2021; 8():707008. PubMed ID: 34621797
[No Abstract] [Full Text] [Related]
6. Association Between Monocyte-to-High-Density Lipoprotein (HDL) Cholesterol Ratio and Proteinuria in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study.
D Y; Sk SR; R NK; Pa A
Cureus; 2023 Sep; 15(9):e45783. PubMed ID: 37872916
[TBL] [Abstract][Full Text] [Related]
7. Effect of empagliflozin use on monocyte high-density lipoprotein ratio and plasma atherogenic index in obese and non-obese type 2 diabetic patients.
Sivgin H; Çetin S
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8090-8100. PubMed ID: 37750637
[TBL] [Abstract][Full Text] [Related]
8. The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes.
Chen JW; Li C; Liu ZH; Shen Y; Ding FH; Shu XY; Zhang RY; Shen WF; Lu L; Wang XQ
Front Endocrinol (Lausanne); 2019; 10():191. PubMed ID: 31019490
[No Abstract] [Full Text] [Related]
9. Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus.
Ya G; Qiu Z; Tianrong P
Clin Lab; 2018 Jun; 64(6):901-906. PubMed ID: 29945315
[TBL] [Abstract][Full Text] [Related]
10. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy.
Efe FK
Pak J Med Sci; 2021; 37(4):1128-1132. PubMed ID: 34290795
[TBL] [Abstract][Full Text] [Related]
11. Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease.
Jia J; Liu R; Wei W; Yu F; Yu X; Shen Y; Chen C; Cai Z; Wang C; Zhao Z; Wang D; Yang L; Yuan G
Front Physiol; 2021; 12():762242. PubMed ID: 34975521
[No Abstract] [Full Text] [Related]
12. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: a cross-sectional study.
Li Y; Liu X; Luo Y
BMC Endocr Disord; 2022 Feb; 22(1):48. PubMed ID: 35216583
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-to-High-Density Lipoprotein Cholesterol Ratio Together With the Lymphocyte-to-Monocyte Ratio in Predicting the Malignancy of the Thyroid Nodule in Patients Complicated With Type 2 Diabetes.
Hu Y; Shen Y; Xia E; Hirachan S; Bhandari A; Jin Z
Clin Med Insights Oncol; 2023; 17():11795549231199920. PubMed ID: 37744427
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy.
Vural G; Gümüsyayla Ş
Medicine (Baltimore); 2018 Oct; 97(42):e12857. PubMed ID: 30334993
[TBL] [Abstract][Full Text] [Related]
15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
16. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin.
Metin N; Turan Ç
J Cosmet Dermatol; 2021 Sep; 20(9):2945-2949. PubMed ID: 33387386
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Diabetic Neuropathy and Uric Acid/High-Density Lipoprotein Ratio in Patients With Type-2 Diabetes Mellitus.
Uzeli U; Doğan AG
Cureus; 2023 Sep; 15(9):e45151. PubMed ID: 37711270
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study.
Huang JB; Chen YS; Ji HY; Xie WM; Jiang J; Ran LS; Zhang CT; Quan XQ
Lipids Health Dis; 2020 Apr; 19(1):59. PubMed ID: 32247314
[TBL] [Abstract][Full Text] [Related]
19. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes.
Mayasari DS; Taufiq N; Hariawan H
BMC Cardiovasc Disord; 2021 Jul; 21(1):362. PubMed ID: 34330221
[TBL] [Abstract][Full Text] [Related]
20. Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus.
Gökçay Canpolat A; Emral R; Keskin Ç; Canlar Ş; Şahin M; Çorapçioğlu D
Biomark Med; 2019 Aug; 13(11):907-915. PubMed ID: 31321988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
